ACI - 7th Annual Hatch-Waxman Conference Series: Paragraph IV Disputes

Now in its seventh iteration, American Conference Institute’s (ACI’s) Paragraph IV Disputes conference is the only event which helps both brand name and generic pharmaceutical companies make sense of changing industry dynamics precipitated by the patent cliff and other factors such as patent reform, regulatory shifts and recent and pending case law.

This is the conference that not only sets the standards for Paragraph IV litigation, but also serves as the annual meeting place for the “who’s who” of pharmaceutical patent litigation. Our faculty of respected and renowned counsel for branded and generic pharmaceutical companies will provide insights on all facets of Paragraph IV litigation: pre-litigation concerns — the commencement of suit — final adjudication and every step in between. Sessions will address the key elements of Paragraph IV litigation in addition to some of the most pressing and recent controversies in this area.

Mark Jansen is one of the speakers on the subject entitled, "Obviousness in Retrospect: Making Sense of Prior Art, Obvious-Type Double Patenting, Inherency and New AIA Controversies."  Jim Stronski is one of the speakers on the topic, "Inequitable Conduct Developments in the Courts and at the PTO: Ethical Considerations for Paragraph IV Cases."